Dr. Guiot’s research focus is brain tumours, and she has worked on the development and integration of advanced molecular techniques in the clinical practice of oncologic neuropathology. She has started multidisciplinary collaborations with clinician-scientists and basic researchers at the Neuro, at the Research Institute of the MUHC, and at the Rosalind and Morris Goodman Cancer Institute.
Dr. Guiot has published more than 100 peer-reviewed articles and more than 150 abstracts. She is currently a co-investigator on several research projects, including a Canadian Cancer Society-CIHR-Brain Canada Foundation 2021 Spark Grant for novel technology applications in cancer prevention and early detection.